
Notas del episodio
This week on H-Span, we are joined by Michael Ringel, PhD, Chief Operating Officer of Life Biosciences.
In this episode, we explore Michael's journey into the longevity space, the groundbreaking work happening at Life Biosciences, as well as their plans to launch human clinical trials for their epigenetic reprogramming asset within the next year.
Palabras clave
longevity
lifespan
health
future
healthcare
biotechnology
geroscience
policymaking
artificial intelligence
politics
science
biotech
skincare
investing
investment
aging
technology
bioscience
biohacking
futurology
